Nicolò Costantino Brembilla is a leading scientist and Privat Docent working at the Geneva University Hospitals and the University of Geneva, Switzerland. Nicolo' is a world-renowned expert on the role of IL-17 cytokines in inflammatory skin disorders.

Trained as a medical biotechnologist, he established and directed the Dermatology Research Laboratory at the University of Geneva, initiating a new line of research on IL-17-dependent crosstalk between stromal and immune cells in the skin. This research led Nicolo' to create new in vitro reconstructed skin models and to develop and patent innovative skin substitutes, in collaboration with Dr Preynat-Seauve, for the treatment of skin healing defects. Prior to his current position, he worked as scientist in the Operational Excellence Research department of Merck Serono, and contributed to the creation of the PRIMM proprietary YOMICS platform, a tool to produce customized polyclonal antibodies as a service. Nicolo’ has contributed significantly to the advancement of scientific knowledge in the immunological and dermatological fields and sits on the board of leading journals in immunology and dermatology.

Nicolo’ Brembilla holds an MBA in innovation and technology management from the Ecole Polytechnique Federale de Lausanne (EPFL) in Switzerland, a PhD in Immunology from the University of Lausanne (Switzerland) and a master’s degree in Medical Biotechnology from the University of Milan (Italy).

Olivier Preynat-Seauve is a PharmD, PhD, academic researcher and Privat Docent working at the University Hospitals of Geneva and at the Faculty of Medicine of the University of Geneva, Switzerland. Olivier has over 20 years of experience working at the interface between stem cells, regeneration, and immunity, with a particular interest in tissue engineering. His main focus is the study of the regulation of adipose-derived stromal cells in various environments, including the healing process. In addition to his academic achievements, his research has led to several patents based on innovative stem cell solutions.

Olivier holds a PhD in cellular and molecular immunology from the University of Grenoble-Alpes (France), and a Swiss FAMH certification in hematology and technical management of the blood banks and immunohaematology laboratory.